Bayer shows consistent success
Bayer $BAYN (+1.29%) surprises with positive figures, despite the challenge of job cuts. On Monday, it was announced that crop protection production in Frankfurt am Main will be discontinued by the end of 2028, affecting around 500 jobs. These drastic measures are part of a comprehensive five-year plan for the Crop Science division, which aims to achieve savings of one billion euros. But the company is not letting this get it down: Things are going well in the pharmaceuticals business, with operating profit from the prescription drugs division shooting up by an impressive 13.4 percent in the first quarter. CEO Anderson, who is facing criticism from investors due to the delayed overall development, attributes this success to a well thought-out organizational model that sets standards in the industry.
Daimler Truck adjusts outlook
In the USA, the situation for Daimler Truck $DTG (-0.65%) looks less encouraging. The management duo, consisting of Karin Radström and CFO Eva Scherer, has revised the annual outlook for 2025 downwards. Instead of the original target of 52 to 54 billion euros in turnover, a range of 48 to 51 billion euros is now given. The reason for this adjustment is the new tariffs introduced by the Trump administration. This uncertainty means that freight forwarders in America do not know how their business will continue and whether they will be able to distribute goods from domestic ports. This has a direct impact on Daimler Truck's customers, who are now more hesitant to order new vehicles. The current challenges present the company with new hurdles to overcome.
Sources:
